The market for peptide and anticoagulant drugs was estimated to be worth US$ 1.86 billion in 2023, and from 2024 to 2030, total revenue is predicted to increase at a rate of 9.3%, approaching US$ 3.48 billion. Peptide and Anticoagulant Drugs Market Overview Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “Peptide and...